View Author
baseline patient percentage atheroma volume atheroma plaque volume percentage study decrease darapladib analysis n log variable value imaging factor diameter blood disease waist circumference change pressure statin statin use cv risk factors syndrome measurement association biomarker stenosi waist plaque morphology circumference cardiovasc table center baseline –percentage risk factors lumen ultrasound predictor atherosclerotic event \0.001 –percentage treatment non-culprit vessels creatinine heart characteristic interest vessel atherosclerosi analyses multivariate univariate baseline pav univariate regression analyses parameter infarction placebo 121 patients blood pressure regression lipoprotein-associated phospholipase stroke diastolic relationship netherland multivariate analysis baseline characteristics 1 year phospholipase atherosclerotic plaque burke ap signal lumen diameter percent atheroma volume body mass index atheroma volume artery
5 Most Recent Publications
|
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: A substudy of the RESOLUTE all comers trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention)
(Article)
Stefanini, G.G. Serruys, P.W.J.C. Linke, A. Klauss, V. Wijns, W. Macaya, C. Garot, P. Mario, C. di Manoharan, G. Kornowski, R. Ischinger, T. Bartorelli, A. Silber, S. Gobbens, P. Windecker, S. Khattab, A.A. Geuns, R-J.M. van Richardt, G. Buszman, P. Kelbæk, H. Boven, A.J. van Hofma, S.H. |
2011-05-31
|
|
Relationship between cardiovascular risk factors and biomarkers with necrotic core and atheroma size: a serial intravascular ultrasound radiofrequency data analysis
(Article)
Garcia-Garcia, H.M. Klauss, V. Gonzalo, N. Garg, S.A. Onuma, Y. Hamm, C.W. Wijns, W. Shannon, J. Serruys, P.W.J.C. |
2011-05-19
|
|
The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: A substudy of the resolute all comers trial
(Article)
Garg, S.A. Serruys, P.W.J.C. Linke, A. Klauss, V. Wijns, W. Macaya, C. Garot, P. Mario, C. di Manoharan, G. Kornowski, R. Ischinger, T. Bartorelli, A. Silber, S. Remortel, E. van Ronden, J. Windecker, S. Wykrzykowska, J.J. Geuns, R-J.M. van Richardt, G. Buszman, P. Kelbæk, H. Boven, A.J. van Hofma, S.H. |
2011-04-01
|
|
Value of age, creatinine, and ejection fraction (acef score) in assessing risk in patients undergoing percutaneous coronary interventions in the 'All-Comers' LEADERS Trial
(Article)
Wykrzykowska, J.J. Garg, S.A. Klauss, V. Corti, R. Eberli, F.R. Wijns, W. Morice, M-C. Mario, C. di Geuns, R-J.M. van Jùni, P. Windecker, S. Serruys, P.W.J.C. Onuma, Y. Vries, A. de Goedhart, D. Morel, M-A.M. Es, E.-A. van Buszman, P. Linke, A. Ischinger, T. |
2011-02-01
|
|
Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization With Biolimus-Eluting Stent With Biodegradable Polymer and Sirolimus-Eluting Stent With Durable Polymer. The LEADERS Trial Substudy
(Article)
Wykrzykowska, J.J. Serruys, P.W.J.C. Eberli, F.R. Wijns, W. Morice, M-C. Mario, C. di Geuns, R-J.M. van Jùni, P. Windecker, S. Onuma, Y. Vries, A. de Es, G.A. van Buszman, P. Linke, A. Ischinger, T. Klauss, V. Corti, R. |
2009-09-01
|
